Paper35322018
Advances in COVID-19 mRNA vaccine development.
Fang E and 9 others. Signal Transduct Target Ther, 2022. Cited by 445 papers, by iCite.
Cite this record
ConductScience Library. Advances in COVID-19 mRNA vaccine development. Papers, record 35322018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35322018
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| COVID-19 Vaccines | Major topic |
| Humans | |
| Pandemics | |
| RNA, Messenger | |
| SARS-CoV-2 | |
| Vaccines, Synthetic | |
| mRNA Vaccines |
Source PubMed
References383
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33524237 | Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription. | Curr Protoc | 2021 | https://conductscience.org/library/papers/33524237 | PubMed |
| 2 | 13956740 | Foreign nucleic acids as the stimulus to make interferon. | Lancet | 1963 | https://conductscience.org/library/papers/13956740 | PubMed |
| 3 | 32728218 | An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. | Nature | 2020 | https://conductscience.org/library/papers/32728218 | PubMed |
| 4 | 31293584 | A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice. | Front Immunol | 2019 | https://conductscience.org/library/papers/31293584 | PubMed |
| 5 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 6 | 24877739 | Model-driven engineering of gene expression from RNA replicons. | ACS Synth Biol | 2015 | https://conductscience.org/library/papers/24877739 | PubMed |
| 7 | 33683637 | BNT162b2 mRNA COVID-19 Vaccine: First Approval. | Drugs | 2021 | https://conductscience.org/library/papers/33683637 | PubMed |
| 8 | 34614327 | Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34614327 | PubMed |
| 9 | 34614329 | Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34614329 | PubMed |
| 10 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 11 | 31465135 | Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands. | Adv Mater | 2019 | https://conductscience.org/library/papers/31465135 | PubMed |
| 12 | 25385608 | In vitro evolution of high-titer, virus-like vesicles containing a single structural protein. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25385608 | PubMed |
| 13 | 34058918 | An overview of rational design of mRNA-based therapeutics and vaccines. | Expert Opin Drug Discov | 2021 | https://conductscience.org/library/papers/34058918 | PubMed |
| 14 | 32483315 | A tale of non-canonical tails: gene regulation by post-transcriptional RNA tailing. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32483315 | PubMed |
| 15 | 23921513 | A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23921513 | PubMed |
| 16 | 22334017 | Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. | Mol Ther | 2012 | https://conductscience.org/library/papers/22334017 | PubMed |
| 17 | 32003222 | Quantitating Endosomal Escape of a Library of Polymers for mRNA Delivery. | Nano Lett | 2020 | https://conductscience.org/library/papers/32003222 | PubMed |
| 18 | 3109912 | Molecular cloning of a pea H1 histone cDNA. | Eur J Biochem | 1987 | https://conductscience.org/library/papers/3109912 | PubMed |
| 19 | 7708765 | Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7708765 | PubMed |
| 20 | 30803823 | mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. | Mol Ther | 2019 | https://conductscience.org/library/papers/30803823 | PubMed |
Cited by314
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 445 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42905254 | Lipid nanoparticle-mediated transcription factor EB mRNA delivery for the treatment of metabolic dysfunction-associated steatotic liver disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42905254 | PubMed |
| 42901509 | A multi-objective sequence engineering framework for rational genetic vaccine design. | J R Soc Interface | 2026 | https://conductscience.org/library/papers/42901509 | PubMed |
| 42888436 | The advances and challenges of mRNA-LNP application in fields of hematology and oncology therapeutics. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42888436 | PubMed |
| 42797601 | Research Progress, Application, and Industrialization Prospects of Circular RNA Vaccines in Viral Diseases. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797601 | PubMed |
| 42713225 | Therapeutic mRNA vaccines for lung cancer: reshaping the tumor microenvironment to enhance anti-tumor immunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42713225 | PubMed |
| 42703288 | Intranasal administration of spike-specific mRNA-LNP confers more protection than the intramuscular route against SARS-CoV-2. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42703288 | PubMed |
| 42591720 | From autism to obesity and beyond: mapping global trends and gaps in pediatric gut microbiota interventions-a bibliometric analysis. | Transl Pediatr | 2026 | https://conductscience.org/library/papers/42591720 | PubMed |
| 42565117 | Beyond the genetic code: orchestrating epigenetic and immune landscapes with multivalent mRNA-exosome vaccines. | Precis Clin Med | 2026 | https://conductscience.org/library/papers/42565117 | PubMed |
| 42514657 | Overcoming Antigenic Drift in PEDV: Broadly Protective Antigen Design and sIgA-Driven Lactogenic Immunity. | Vet Sci | 2026 | https://conductscience.org/library/papers/42514657 | PubMed |
| 42501279 | Computational Design of a Broad-Spectrum Multi-Epitope mRNA Vaccine Candidate for Mammarenaviruses. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42501279 | PubMed |
| 42482987 | Animal virus-host interactions mediated by non-coding RNAs. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42482987 | PubMed |
| 42478133 | Evaluation of the Prevention and Control Efficacy of Different Immunization Regimens Against Porcine Epidemic Diarrhea Virus. | Transbound Emerg Dis | 2026 | https://conductscience.org/library/papers/42478133 | PubMed |
| 42446520 | In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies. | Elife | 2026 | https://conductscience.org/library/papers/42446520 | PubMed |
| 42440792 | Use of the Peptide Barcode Method for Efficient Screening of mRNA Expression Control Sequence. | Mass Spectrom (Tokyo) | 2026 | https://conductscience.org/library/papers/42440792 | PubMed |
| 42369559 | mRNA vaccines against viral pathogens: molecular design, delivery systems, and clinical applications. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42369559 | PubMed |
| 42368401 | Trivalent mRNA-LNP Vaccine Induces Robust Humoral and Cellular Immunity in Mice: Preclinical Evaluation for Porcine Enteric Coronaviruses. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42368401 | PubMed |
| 42327479 | Efficacy and Safety of Messenger RNA Vaccines. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42327479 | PubMed |
| 42316313 | A bivalent mRNA-LNP vaccine confers broad-spectrum protection against both homologous and heterologous H5/H7 highly pathogenic avian influenza viruses in SPF chickens. | Vet Res | 2026 | https://conductscience.org/library/papers/42316313 | PubMed |
| 42297566 | Encapsulin-Protected Immunotherapeutic Complexes: Bacteria-Derived Nanoparticles for mRNA Delivery to Eukaryotic Cells. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42297566 | PubMed |
| 42293741 | Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42293741 | PubMed |
Genes62
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35322018
GET https://conductscience.org/api/papers/v1/35322018/references?page=2